← Browse by Condition
Medical Condition

schizoaffective disorder

Total Trials
5
Recruiting Now
5
Trial Phases
Phase 4

ClinicalMetric tracks all active clinical trials for schizoaffective disorder sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — schizoaffective disorder Clinical Trials

How many clinical trials are currently recruiting for schizoaffective disorder?
ClinicalMetric currently tracks 5 actively recruiting clinical trials for schizoaffective disorder, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 5. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for schizoaffective disorder?
schizoaffective disorder research spans Phase 4 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a schizoaffective disorder clinical trial?
Eligibility criteria for schizoaffective disorder trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 4
1
Top Sponsors
Corporal Michael J. Crescenz VA Medical Center 1 trial
Charite University, Berlin, Germany 1 trial
Northwell Health 1 trial
University of California, San Diego 1 trial
University of Jyvaskyla 1 trial

Recruiting Clinical Trials

NCT03495024 Phase 4
Recruiting
Smoking Cessation With Varenicline in Schizophrenia: Antipsychotic-Induced Neurological Symptoms as Correlates
Enrollment
10 pts
Location
United States
Sponsor
Corporal Michael J. Crescenz V...
View Trial →
NCT07395206
Recruiting
Acceptability, Feasibility and Preliminary Outcomes of the Kiso Mind App for Outpatients With Schizophrenia Spectrum Disorders
Enrollment
60 pts
Location
Germany
Sponsor
Charite University, Berlin, Ge...
View Trial →
NCT07703670
Recruiting
MicroRNAs as Biomarkers in First Episode Schizophrenia
Enrollment
160 pts
Location
United States
Sponsor
Northwell Health
View Trial →
NCT07098169
Recruiting
Randomized Clinical Trial of iTEST: A Blended Intervention Targeting Introspective Accuracy
Enrollment
201 pts
Location
United States
Sponsor
University of California, San ...
View Trial →
NCT06005766
Recruiting
The Efficacy of Metacognitive Skills Training in the Context of Forensic Psychiatric Care
Enrollment
85 pts
Location
Finland
Sponsor
University of Jyvaskyla
View Trial →

Related Conditions

schizophrenia (3) psychotic disorders (2) tobacco smoking (1) tardive dyskinesia (1) parkinsonism (1) psychosis (1) primary psychotic disorders (1) schizophrenia spectrum disorders (1) schizophrenia disorder (1) schizophreniform disorder (1) psychosis not otherwise specified nos (1) schizophrenia disorders (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology